InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by DiPaolo Mark, Director. Insider active across 3 companies, notably Innoviva, Inc.. Aggregated, 8 filings have been recorded. Activity tracked since 14 May 2021. The latest transaction was disclosed on 19 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations8 total
12,077 shares0Common StockSEC:0001104659-25-051748:0
838 sharesAmerican Depositary SharesSEC:0000950170-25-056925:0
437 shares@ US$9.11100.0% of flowAmerican Depositary SharesSEC:0000950170-25-056925:1
13,923 shares0Common StockSEC:0001104659-24-073442:0
16,495 shares0Common StockSEC:0001104659-23-064210:0
12,647 shares0Common StockSEC:0001567619-22-009043:0
17,482 shares0Common StockSEC:0001567619-21-010828
17,482 shares0Common StockSEC:0001567619-21-010828:0
8 of 8 declarations
About DiPaolo Mark
Mark DiPaolo is a Director at Innoviva, Inc. He participates in the governance of the company, bringing his expertise in the biopharmaceutical sector. Mark plays an active role in strategic decision-making for the firm.
